Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Direvo Introduces BluZy™-Product Development Platform

Published: Tuesday, October 09, 2012
Last Updated: Tuesday, October 09, 2012
Bookmark and Share
New innovative enzyme technologies improving economics for the ethanol and livestock feeding industries.

Direvo Industrial Biotechnology GmbH is introducing its BluZy™-product development platform, delivering innovative biology-based solutions to improve economics of renewable fuels and livestock feeding markets.

Direvo´s most advanced product, BluZy™-D, substantially improves the nutritional value of DDGS and offers a cost effective alternative to corn and soy bean meal in broiler production.

Further product developments are in pipeline, focusing to get the most and best out of every bushel corn.

“Direvo´s innovative enzyme technology, our BluZy™- product development platform, has the potential to turn corn-ethanol plants into true biorefineries” commented Direvo´s CEO Jörg Riesmeier.

Escalating grain prices are putting enormous pressure on ethanol processors and animal feed markets.

Ethanol plants are shutting down due to low margins and are focusing efforts to identify technologies that will decrease production cost and add value to their co-product streams.

Feedlot managers, on the other side, are searching for new feed ingredients to reduce feed cost and reduce dependency on the volatility of commodity corn and soybean markets.

The ethanol and animal feed industry have developed an important interdependence in the last few years through Distillers Dried Grains with Solubles (DDGS), a major source of revenues for corn-based ethanol producers and a popular substitute for corn and soybean meal in animal feed rations.

DDGS is a popular feed ingredient and is providing much of the needed protein, energy, phosphate, vitamins and other important nutrients to livestock.

While its use grew rapidly in beef and cattle production, feeding DDGS to monogastric animals remains limited, mainly due to its high fiber content and low digestibility. BluZy™-D, was developed to provide DDGS with high nutritional value for the broiler industry.

The key objective of BluZy™-D is to increase fiber digestibility, nutrient absorption and enable higher inclusion rates to reduce costs of feed formulations.

The performance of BluZy™-D has been verified in initial animal trials as compared to commercial DDGS available on the market. The production of this high value feed ingredient is currently being scaled up and will be further evaluated in broiler trials at major universities.

In addition, the portfolio includes biotechnologies to improve ethanol production efficiency, by improving processability, reducing energy consumption and improving the consistency of co-product streams.

All products of the BluZy-D™ portfolio are tailor made for the corn ethanol industry and designed to get the most and best out of every bushel corn.

Direvo’s mission is to continuously identify the industries’ needs, understand their issues and deliver biological solutions that reduce costs and improve margins along the value chain.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Direvo Reaches Milestone in Consolidated Bioprocessing of Lignocellulose to Lactic Acid
Company ferments lactic acid on pilot scale in a single-step-synthesis.
Tuesday, March 12, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Analysis Technique for Chiral Activity in Molecules
Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Antibiotics on Our Plates 'Could Lead to Health Catastrophe'
Two medical experts from The University of Queensland are urging China to curb its use of antibiotics in animals to avoid what could be a ‘major health catastrophe’ for humans.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos